Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


CENTRO DE INMUNOLOGIA MOLECULAR

CENTRO DE INMUNOLOGIA MOLECULAR Patent applications
Patent application numberTitlePublished
20120121605ANTI SULFATIDES AND ANTI SUFATED PROTEOGLYCANS ANTIBODIES AND THEIR USE - The present invention relates to the biotechnology and particularly with new products for use in human health.05-17-2012
20100197011METHOD OF OBTAINING CELL LINES IN A PROTEIN-FREE MEDIUM AND CELL LINES THUS OBTAINED - A method of recovering mammalian cell clones adapted to serum and protein-free media is disclosed. The procedure includes a two-stage adaptation process to grow in that condition. A critical protein concentration interval is disclosed in which cells must grow in order to gain the capacity to survive in serum and protein-free condition, once the cells have grown at the critical interval concentrations, subsequent decreases of the concentration will affect neither viability nor cellular doubling time. The critical protein concentration interval is cell line specific. Furthermore, mammalian cells clones are disclosed, which are stable in serum- and protein-free media for at least 40 generations; additionally, clones disclosed express a recombinant product. The cell clones disclosed produce the humanized anti-EGF-R antibody hR3, the humanized anti-CD6 antibody T1hT, the chimeric anti CD3 antibody T3Q, or fragments thereof.08-05-2010
20100196412HOMOGENEOUS VACCINE COMPOSITION FOR THE TUMOR TREATMENT AND ITS OBTAINING METHOD - The present invention relates to the biotechnological field and particularly to the human health. More particularly, the present invention relates to a vaccine composition for therapeutic use in cancer patients.08-05-2010

Patent applications by CENTRO DE INMUNOLOGIA MOLECULAR